Sharda Cropchem
987.80
-48.05(-4.64%)
Market Cap₹8,911.98 Cr
PE Ratio16.58
IndustryChemicals
Company Performance:
1D-4.64%
1M+17.64%
6M-12.07%
1Y+70.21%
5Y+251.41%
View Company Insightsright
More news about Sharda Cropchem
30Oct 25
Sharda Cropchem Reports Robust Q2 Performance with 19% Revenue Growth and 77% Surge in Net Profit
Sharda Cropchem Limited announced robust Q2 FY2025-26 financial results. Revenue increased by 19.6% to ₹9,291.00 crore. EBITDA grew by 33% to ₹1,330.00 crore, with EBITDA margin expanding to 14.30%. Net profit surged by 76.9% to ₹743.00 crore. The company's performance indicates strong demand for its products and improved operational efficiency in the agrochemicals market.
 no imag found
20Sept 25
Sharda Cropchem Targets Over 18% EBITDA Margins in FY26 Amid Improving Market Conditions
Sharda Cropchem aims for EBITDA margins over 18% in FY26, driven by stabilizing prices, stable Euro-Dollar rates, operational efficiencies, and normalized inventory levels. The company reported strong Q1 growth and maintains a robust cash position of Rs 790 crore. Dividends were doubled in FY25 with potential for further increases. The company remains unaffected by U.S. tariffs due to its ability to pass on costs to customers.
 no imag found
25Jul 25
Sharda Cropchem Reports Strong Q1 Results, Targets 15% Revenue Growth
Sharda Cropchem Limited reported robust Q1 financial results with revenue up 25% to Rs. 984.80 crore, EBITDA increasing 67% to Rs. 142.20 crore, and net profit surging 424% to Rs. 142.80 crore. The company saw growth in both Agrochemicals (25% increase) and Non-Agrochemicals (31% increase) segments. Europe remained a key contributor with 43% growth in Agrochemicals. The company aims for 15% revenue growth and 15-18% EBITDA margins for the fiscal year, supported by a strong pipeline of 2,981 product registrations and 1,021 pending applications. Sharda Cropchem maintains a debt-free status with Rs. 791.00 crore in cash and investments.
 no imag found
25Jul 25
Sharda Cropchem Reports Strong Q1 Results with 25% Revenue Growth and 424% PAT Surge
Sharda Cropchem Limited has reported impressive Q1 results with revenue increasing by 25% to ₹985.00 crores and profit after tax soaring by 424% to ₹143.00 crores. The company's EBITDA grew by 67% to ₹142.00 crores, with margins improving to 14.40%. The agrochemical segment, contributing 86% of total revenue, grew by 25% year-on-year. Overall volume growth was approximately 13%, with Europe remaining the largest market. The company's working capital management improved, reducing working capital by 18 days to 100 days.
 no imag found
16May 25
Sharda Cropchem Sets Ambitious 15%+ Top Line Growth Target for FY '26
Sharda Cropchem, a key agrochemical player, has announced plans to increase its top line by over 15% in FY2026. The company also anticipates improved gross margins in the upcoming financial year, driven by expected price increases across its product range. This growth strategy reflects the company's confidence in its market position and product portfolio, despite industry challenges.
 no imag found
14May 25
Sharda Cropchem Reports Strong Q4 Financial Results with 42.7% Net Profit Growth
Sharda Cropchem, an agrochemical company, reported a significant increase in its Q4 FY financial performance. The consolidated net profit rose to ₹204.00 crore, marking a 42.7% year-over-year growth. Revenue increased to ₹1830.00 crore from ₹1312.00 crore, while EBITDA grew to ₹303.00 crore from ₹253.00 crore. However, the EBITDA margin decreased to 16.58% from 19.28% compared to the same period last year.
 no imag found
Sharda Cropchem
987.80
-48.05
(-4.64%)
1 Year Returns:+70.21%
Industry Peers
UPL
664.95
(-5.54%)
PI Industries
3,098.00
(-3.05%)
Sumitomo Chemical
417.25
(+1.86%)
Bayer Crop Science
4,397.60
(-1.54%)
Sharda Cropchem
987.80
(-4.64%)
Rallis
261.65
(-4.75%)
Dhanuka Agritech
1,089.60
(-2.60%)
NACL Industries
137.56
(-5.00%)
Bharat Rasayan
1,830.10
(-1.95%)